Literature DB >> 7120281

Conformational analysis of the ergot alkaloids ergotamine and ergotaminine.

L Pierri, I H Pitman, I D Rae, D A Winkler, P R Andrews.   

Abstract

Conformational analyses by 1H NMR and potential-energy calculations are reported for the ergot alkaloids ergotamine and ergotaminine, both as free bases and as the protonated species. In the neutral forms in CDCl3. two strong intramolecular hydrogen bonds fix the molecules in folded conformations, but the protonated species adopt a more extended conformation, with a single intramolecular hydrogen bond. Of the 24 alternative conformations available to ergotamine, the most likely biologically active species in environments with low dielectric constants, e.g., the presumed ergotamine binding site, is the folded, hydrogen-bonded conformation observed for the neutral molecule in CDCl3 solution.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7120281     DOI: 10.1021/jm00350a010

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  The biologically active conformation of ergot alkaloids.

Authors:  J Kidric; D Kocjan; D Hadzi
Journal:  Experientia       Date:  1986-03-15

2.  Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).

Authors:  Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Alexander Stratford; Simon P Elliott; Khoa Hoang; Jason Wallach; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2015-10-12       Impact factor: 3.345

3.  Ergometrinine.

Authors:  Stefan Merkel; Robert Köppen; Matthias Koch; Franziska Emmerling; Irene Nehls
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-08-11

4.  Ergotaminine.

Authors:  Stefan Merkel; Robert Köppen; Matthias Koch; Franziska Emmerling; Irene Nehls
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-04

5.  Assessment of the vasoactive effects of the (S)-epimers of ergot alkaloids in vitro.

Authors:  Jensen E Cherewyk; Sarah E Parker; Barry R Blakley; Ahmad N Al-Dissi
Journal:  J Anim Sci       Date:  2020-07-01       Impact factor: 3.159

6.  Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine.

Authors:  Despoina Aslanoglou; Suzanne Bertera; Laura Friggeri; Marta Sánchez-Soto; Jeongkyung Lee; Xiangning Xue; Ryan W Logan; J Robert Lane; Vijay K Yechoor; Peter J McCormick; Jens Meiler; R Benjamin Free; David R Sibley; Rita Bottino; Zachary Freyberg
Journal:  iScience       Date:  2022-07-19

7.  Contractile Response of Bovine Lateral Saphenous Vein to Ergotamine Tartrate Exposed to Different Concentrations of Molecularly Imprinted Polymer.

Authors:  Manoj B Kudupoje; James L Klotz; Alexandros Yiannikouris; Karl A Dawson; Kyle R McLeod; Eric S Vanzant
Journal:  Toxins (Basel)       Date:  2018-01-30       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.